MONDELEZ INTERNATIONAL INC-A (MDLZ)
US6092071058 - Common Stock
We assign a fundamental rating of 5 out of 10 to MDLZ. MDLZ was compared to 93 industry peers in the Food Products industry. While MDLZ belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MDLZ is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MDLZ was profitable.
In the past year MDLZ had a positive cash flow from operations.
Each year in the past 5 years MDLZ has been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
MDLZ has a Return On Assets of 5.53%. This is in the better half of the industry: MDLZ outperforms 67.39% of its industry peers.
MDLZ's Return On Equity of 15.06% is amongst the best of the industry. MDLZ outperforms 81.52% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.68%, MDLZ belongs to the top of the industry, outperforming 84.78% of the companies in the same industry.
MDLZ had an Average Return On Invested Capital over the past 3 years of 6.55%. This is in line with the industry average of 7.79%.
The last Return On Invested Capital (9.68%) for MDLZ is above the 3 year average (6.55%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 15.06% | ||
| ROIC | 9.68% |
ROA(3y)5.72%
ROA(5y)5.7%
ROE(3y)14.27%
ROE(5y)14.03%
ROIC(3y)6.55%
ROIC(5y)6.31%
1.3 Margins
MDLZ's Profit Margin of 11.87% is amongst the best of the industry. MDLZ outperforms 88.04% of its industry peers.
In the last couple of years the Profit Margin of MDLZ has remained more or less at the same level.
With an excellent Operating Margin value of 19.17%, MDLZ belongs to the best of the industry, outperforming 96.74% of the companies in the same industry.
In the last couple of years the Operating Margin of MDLZ has remained more or less at the same level.
MDLZ has a Gross Margin of 41.69%. This is amongst the best in the industry. MDLZ outperforms 94.57% of its industry peers.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.17% | ||
| PM (TTM) | 11.87% | ||
| GM | 41.69% |
OM growth 3Y0.4%
OM growth 5Y0.42%
PM growth 3Y0.97%
PM growth 5Y1.49%
GM growth 3Y-0.93%
GM growth 5Y-0.86%
2. Health
2.1 Basic Checks
MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, MDLZ has less shares outstanding
Compared to 5 years ago, MDLZ has less shares outstanding
The debt/assets ratio for MDLZ has been reduced compared to a year ago.
2.2 Solvency
MDLZ has an Altman-Z score of 2.47. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of MDLZ (2.47) is comparable to the rest of the industry.
MDLZ has a debt to FCF ratio of 5.12. This is a neutral value as MDLZ would need 5.12 years to pay back of all of its debts.
MDLZ has a Debt to FCF ratio of 5.12. This is in the better half of the industry: MDLZ outperforms 71.74% of its industry peers.
MDLZ has a Debt/Equity ratio of 0.60. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio (0.60) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 5.12 | ||
| Altman-Z | 2.47 |
ROIC/WACC1.24
WACC7.81%
2.3 Liquidity
A Current Ratio of 0.77 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a worse Current ratio (0.77) than 84.78% of its industry peers.
A Quick Ratio of 0.63 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a worse Quick ratio (0.63) than 72.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.22% over the past year.
The Earnings Per Share has been growing slightly by 6.38% on average over the past years.
The Revenue has grown by 9.85% in the past year. This is quite good.
The Revenue has been growing slightly by 6.79% on average over the past years.
EPS 1Y (TTM)11.22%
EPS 3Y8.1%
EPS 5Y6.38%
EPS growth Q2Q6.74%
Revenue 1Y (TTM)9.85%
Revenue growth 3Y10.66%
Revenue growth 5Y6.79%
Revenue growth Q2Q1.35%
3.2 Future
The Earnings Per Share is expected to grow by 6.69% on average over the next years.
Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y8.41%
EPS Next 2Y8.37%
EPS Next 3Y8.51%
EPS Next 5Y6.69%
Revenue Next Year3.05%
Revenue Next 2Y3.72%
Revenue Next 3Y3.95%
Revenue Next 5Y4.05%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
MDLZ is valuated rather expensively with a Price/Earnings ratio of 20.90.
Compared to the rest of the industry, the Price/Earnings ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 67.39% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MDLZ to the average of the S&P500 Index (28.05), we can say MDLZ is valued slightly cheaper.
With a Price/Forward Earnings ratio of 18.12, MDLZ is valued on the expensive side.
71.74% of the companies in the same industry are more expensive than MDLZ, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of MDLZ to the average of the S&P500 Index (20.30), we can say MDLZ is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.9 | ||
| Fwd PE | 18.12 |
4.2 Price Multiples
MDLZ's Enterprise Value to EBITDA is on the same level as the industry average.
MDLZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 60.87% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.42 | ||
| EV/EBITDA | 13.83 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MDLZ has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)3.28
EPS Next 2Y8.37%
EPS Next 3Y8.51%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.40%, MDLZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.51, MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, MDLZ has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.4% |
5.2 History
The dividend of MDLZ is nicely growing with an annual growth rate of 11.47%!
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.47%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
MDLZ pays out 51.49% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP51.49%
EPS Next 2Y8.37%
EPS Next 3Y8.51%
MONDELEZ INTERNATIONAL INC-A
NASDAQ:MDLZ (5/8/2024, 7:05:07 PM)
After market: 70.43 0 (0%)70.43
-0.46 (-0.65%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap94.74B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.4% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.9 | ||
| Fwd PE | 18.12 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.48
PEG (5Y)3.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 15.06% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 19.17% | ||
| PM (TTM) | 11.87% | ||
| GM | 41.69% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)11.22%
EPS 3Y8.1%
EPS 5Y
EPS growth Q2Q
EPS Next Y8.41%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.85%
Revenue growth 3Y10.66%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y